Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 661-665

  Bai, Tao ^a   Tanaka, Tetsuji ^a   Yukawa, Kazunori ^a   Maeda, Masanobu ^a   Umesaki, Naohiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Death associated protein kinase; DNA methylation; Ovary; Uterus

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); SULFITE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CARCINOMA; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; METABOLISM; MOUSE; OVARY TUMOR; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR CELL LINE; UTERUS CANCER; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SULFITES; UTERINE NEOPLASMS;

EID: 3042544031     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.661     Document Type: Article

References (26)

1. 2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 16: 998-1008, 1997.
2. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E and Kimchi A: DAP kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 146: 141-148, 1999. (Pubitemid 29349970)
3. Raveh T, Droguett G, Horwitz MS, De Pinho RA and Kimchi A: DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 3: 1-7, 2001. (Pubitemid 32114825)
4. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L and Kimchi A: DAP kinase links the control of apoptosis to metastasis. Nature 390: 180-184, 1997. (Pubitemid 27507988)
5. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME and Kimchi A: DAP kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15: 403-407, 1997. (Pubitemid 27370989)
6. Nakatsuka S, Takakuwa T, Tomita Y, Miwa H, Matsuzuka F and Aozasa K: Role of hypermethylation of DAP kinase CpG island in the development of thyroid lymphoma. Lab Invest 80: 1651-1655, 2000.
7. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG and Sidransky D: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895, 2000. (Pubitemid 30129522)
8. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999. (Pubitemid 29062958)
9. Katzenellenbogen RA, Baylin SB and Herman JG: Hypermethylation of the DAP kinase CpG island is a common alteration in B-cell malignancies. Blood 93: 4347-4353, 1999. (Pubitemid 29279278)
10. Lee TL, Leung WK, Chan MWY, Ng EKW, Tong JHM, Lo KW, Chung SCS, Sung JJY and To KF: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002. (Pubitemid 34633732)
11. Satoh A, Toyota M, Itoh F, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T and Imai K: DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer 86: 1817-1823, 2002. (Pubitemid 34712929)
12. Dong SM, Kim HS, Rha SH and Sidransky D: Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7: 1982-1986,2001. (Pubitemid 32994835)
13. Grunau C, Clark SJ and Rosenthal A: Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 29: 65, 2001.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
15. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA and Crowell RE: Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62: 2370-2377, 2002. (Pubitemid 34411720)
16. Lancillotti F, Giandomenico V, Affabris E, Fiorucci G, Romeo G and Rossi GB: Interferon alpha-2β and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res 55: 3158-3164, 1995.
17. Ishiwata I, Ishiwata C, Soma M, Ono I, Nakaguchi T, Nozawa S and Ishikawa H: Differences between cell lines of uterine cervical glassy cell carcinoma and large cell non-keratinizing squamous cell carcinoma. Anal Quant Cytol Histol 12: 290-298, 1990. (Pubitemid 20298358)
18. Hsu SH, Schacter BZ, Delaney NL, Miller TB, McKusick VA, Kennett RH, Bodmer JG, Young D and Bodmer WF: Genetic characteristics of the HeLacell. Science 191: 292-394, 1976.
19. Ishiwata I, Ishiwata C, Soma M, Arai J and Ishikawa H: Establishment of human endometrial adenocarcinoma cell line containing estradiol-17β and progesterone. Gynecol Oncol 17: 281-290, 1984. (Pubitemid 14174339)
20. Nishida M, Kasahara K, Kaneko M, Iwasaki H and Hayashi K: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynecol Jpn 37: 1103-1111, 1985. (Pubitemid 15047811)
21. Satyaswaroop PG, Frost A and Gurpide E: Metabolism and effects of progesterone in the human endometrial adenocarcinoma cell line HEC-1. Steroids 35: 21-37, 1980. (Pubitemid 11252899)
22. Kidera Y, Yoshimura T, Ohkuma Y, Iwasaka T and Sugimori H: Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary. Acta Obstet Gynecol Jpn 37: 1820-1824, 1985. (Pubitemid 15241762)
23. Uehara S, Abe H, Hoshiai H, Yajima A and Suzuki M: Establishment and characterization of ovarian endometrioid carcinoma cell line. Gynecol Oncol 17: 314-325, 1984. (Pubitemid 14174344)
24. Rasilo ML: Fractination of large glycopeptides of human terato-carcinoma-derived cells by concanavalin A-Sepharose chromatography. Biochem Cell Biol 58: 281-286, 1980.
25. Ohkawa K, Takada K, Takizawa N, Hatano T, Tsukada Y and Matsuda M: Clear cell carcinoma of the human ovary synthesizes and secretes a transferring with microheterogeneity of lectin affinity. FEBS Lett 270: 19-23, 1990. (Pubitemid 20285713)
26. Motoyama T: Biological characterization including sensitivity to mitomycin C of cultured human ovarian cancers. Acta Obstet Gynecol Jpn 33: 1197-1204, 1981.